|
|||||||||||||||||||||||||||||||||||||||||||||||||||||
2014 ESC Guidelines on Diagnosis and Management of Hypertrophic Cardiomyopathy (Eur Heart J 2014 – doi:10.1093/eurheartj/ehu284)
O’Mahony C et al Eur Heart J (2014) 35 (30): 2010-2020 |
|||||||||||||||||||||||||||||||||||||||||||||||||||||
HCM Risk-SCD should not be used in:
Caution should be exercised when assessing the SCD in patients following invasive reduction in left ventricular outflow tract obstruction with myectomy or alcohol septal ablation. Pending further studies, HCM-RISK should be used cautiously in patients with a maximum left ventricular wall thickness ≥35 mm.
©The European Society of Cardiology 2014 Best viewed in Mozilla Firefox, Google Chrome, Safari or Internet Explorer 8.0 and above.Problems with the calculator? Contact Us! |